Evidence map›Paper›PMID 34885144›Full record

ArticleCancers2021

Prognostic Features of Near-Infrared Spectroscopy Following Primary Radical Prostatectomy.

Tijl Vermassen, Jonas Himpe, Renaat Coopman, Charles Van Praet, Nicolaas Lumen, Sylvie Rottey, Joris Delanghe

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tijl VermassenDepartment of Medical Oncology, University Hospital Ghent, 9000 Ghent, Belgium.ORCID 0000-0002-1335-9966
Jonas HimpeDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, 9000 Ghent, Belgium.
Renaat CoopmanDepartment of Plastic, Reconstructive and Aesthetic Surgery, University Hospital Ghent, 9000 Ghent, Belgium.ORCID 0000-0002-0580-9074
Charles Van PraetDepartment of Urology, University Hospital Ghent, 9000 Ghent, Belgium.
Nicolaas LumenDepartment of Urology, University Hospital Ghent, 9000 Ghent, Belgium.
Sylvie RotteyDepartment of Medical Oncology, University Hospital Ghent, 9000 Ghent, Belgium.
Joris DelangheDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-5702-6792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnly a few biomarkers have been evaluated for their prognostic value with regard to biochemical recurrence (BCR) following primary radical prostatectomy. We explored the possibilities of using near-infrared (NIR) spectroscopy as a prognostic biomarker for BCR-free survival (BCR-FS).

methodsTissue specimens from 82 prostate cancer patients were obtained. Formalin-fixed paraffin-embedded slides (hematoxylin-eosin-stained) were analyzed using NIR spectroscopy. Prognostic features for BCR-FS were determined following normalization of the spectra.

resultsSeveral differences were found throughout the NIR spectrum for the patients with or without BCR, for both the first derivative and second derivative of the NIR spectrum. Following categorization and Cox regression analysis, spectral regions at 5236 cm

conclusionsWe demonstrated NIR spectral variations between patients with or without BCR, which have been shown to have prognostic value. This easy-to-use technique could possibly further improve post-primary radical prostatectomy monitoring and swift referral to adjuvant local therapies. Further elaboration is highly recommended to fully elucidate these variations and to gain a deeper insight into the changing chemical and physical compositions of the prostate tumor architecture.

Indexed as

biochemical recurrencelocal treatmentNIRprognosisprostate cancerspectroscopy

Identifiers

PMID34885144
PMCPMC8656494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.